IDXX IDEXX Laboratories, Inc. - Common Stock

NAS · US · Healthcare · Diagnostics & Research · idexx.com

518.39USD+0.12%Mkt Cap: 40.89B $P/E: 36.404d ago

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It opera…

Industry Peers

Diagnostics & Research

Screen all

TMO

Thermo Fisher Scientific Inc Common Stock

$242.11BUSDP/E 35.5

DHR

Danaher Corporation Common Stock

$150.48BUSDP/E 38.2

NTRA

Natera, Inc. - Common Stock

Agilent Technologies, Inc. Common Stock

$47.30BUSDP/E 33.1

IQV

IQVIA Holdings, Inc. Common Stock

$42.50BUSDP/E 32.2

WAT

Waters Corporation Common Stock

$41.75BUSDP/E 107.4

ILMN

Illumina, Inc. - Common Stock

$41.23BUSDP/E 50.8

MTD

Mettler-Toledo International, Inc. Common Stock

$29.78BUSDP/E 34.0

DGX

Quest Diagnostics Incorporated Common Stock

$25.75BUSDP/E 25.0

Labcorp Holdings Inc. Common Stock

$25.02BUSDP/E 25.5

Guardant Health, Inc. - Common Stock

$23.86BUSD

RVTY

Revvity, Inc. Common Stock

$16.91BUSDP/E 72.5

MEDP

Medpace Holdings, Inc. - Common Stock

$16.73BUSDP/E 35.2

ERF

Eurofins Scientific SE

$13.92BUSDP/E 26.0

CRL

Charles River Laboratories International, Inc. Common Stock

$13.85BUSD

ICLR

ICON plc - Ordinary Shares

Qiagen N.V. Common Shares

$9.24BUSDP/E 22.7

GRAL

GRAIL, Inc. - Common Stock

$6.40BUSD

Key Statistics

Company

Market Cap40.89B USD

Enterprise Value41.74B USD

Revenue (TTM)4.55B USD

Gross Profit2.66B USD

Net Income (TTM)1.06B USD

Revenue/Share57.17 USD

Last Price518.39 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees11.0K

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)36.40

P/E (Forward)30.97

PEG2.84

EV/EBITDA25.74

EV/Revenue9.17

P/S8.98

P/B25.36

EPS (TTM)14.23

EPS (Forward)16.74

52W Range

500.617% of range769.98

52W High769.98 USD

52W Low500.61 USD

Profitability

Gross Margin61.80%

Oper. Margin34.98%

EBITDA Margin35.62%

Profit Margin24.62%

ROE65.99%

ROA31.62%

Growth

Revenue Growth9.70%

Earnings Growth17.60%

Cash Flow & Leverage

Operating CF1.18B USD

CapEx (TTM)138.23M USD

FCF Margin19.97%

FCF Yield2.22%

Net Debt899.15M USD

Net Debt/EBITDA0.55

Balance Sheet

Debt/Equity0.61

Current Ratio1.17

Quick Ratio0.73

Book Value/Sh20.45 USD

Cash/Share2.50 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split2:1

Split DateJun 16, 2015

Analyst Consensus

Rating2.2 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)701.33 USD

Upside (mean)+35.3%

Target Range470.00 USD – 805.00 USD

470.00+35.3% to mean805.00

# Analysts12

Ownership

Shares Out.78.88M

Float78.50M

Insiders0.22%

Institutions96.72%

Short Interest

Short Ratio3.8d

Short % Float2.78%

Short % Out.2.43%

Shares Short1.92M

Short (prev mo.)1.94M

Technical

SMA 50543.80 (-4.7%)

SMA 200587.95 (-11.8%)

Beta1.54

S&P 52W Chg14.58%

Avg Vol (30d)464.65K

Avg Vol (10d)416.55K

Technical Indicators

RSI (14)43.1

MACD-7.1227

MACD Signal-9.0432

MACD Hist.+1.9205

BB Upper538.73 USD

BB Middle519.87 USD

BB Lower501.01 USD

BB Width7.26%

ATR (14)13.24 USD

Vol Ratio (20d)0.58x